Continue to Site
CSL, including CSL Behring in the Drug Discovery & Development Pharma 50

Hemophilia gene therapy Hemgenix sets record for world’s most expensive drug 

methicillin-resistant staphylococcus aureus

Combatting the rise of antimicrobial resistance 


Why the TAAR1 agonist ulotaront holds promise for schizophrenia


Why GSK is pulling multiple myeloma drug Blenrep from U.S. market

Fujifilm Logo

Fujifilm spending $188M on new cell culture media plant


Eisai prepares to share more findings for Alzheimer’s antibody lecanemab


Q&A: Getting solid form selection right in early drug development


Tzield drug that can delay onset of type 1 diabetes has a pricetag close to $200,000

bivalent COVID-19 vaccine

Pfizer and BioNTech’s updated bivalent booster retains protection against new omicron sublineages